The medical device market in Hong Kong is regulated by the Medical Device Division (MDD) of the Department of Health. To ensure that medical devices meet standards of safety, quality, and performance, the authorities have established the Medical Device Administrative Control System (MDACS). This system provides a structured framework for the listing of medical devices and in vitro diagnostic devices, ensuring that healthcare providers and the public have access to verified information regarding the products circulating in the market.
Under the MDACS, medical devices are categorized based on their inherent risks to patients and users. This classification determines the specific administrative procedures and documentation required for a successful listing.
General medical devices are divided into four risk-based classes: Class I, Class II, Class III, and Class IV. Currently, the MDACS listing process focuses on Class II, Class III, and Class IV devices, which represent moderate to high-risk categories. Similarly, in vitro diagnostic medical devices (IVDMD) are classified from Class A to Class D. For high-risk products, such as implantable devices or complex diagnostic systems, the scrutiny during the review process is significantly higher to ensure the protection of public health.
To qualify for listing in the MDACS, manufacturers must demonstrate that their devices conform to the Essential Principles of Safety and Performance. This involves providing evidence of a robust quality management system, which is typically substantiated through ISO 13485 certification. The MDD recognizes conformity assessment results from major international regulatory jurisdictions. Manufacturers who have already secured approvals in markets such as China, the United States, the European Union, Australia, Canada, or Japan can leverage these existing certifications to support their application in Hong Kong.
A fundamental requirement of the MDACS for non-resident manufacturers is the appointment of a Local Responsible Person (LRP). The LRP serves as the official point of contact within Hong Kong and assumes several critical administrative and legal responsibilities.
The LRP must be a legal entity or a natural person with a valid business registration in Hong Kong. They are formally designated by the manufacturer through a letter of designation to manage the listing process via the Medical Device Information System (MDIS). The LRP is responsible for ensuring that the application data is accurate and for maintaining communication with the Medical Device Division throughout the lifecycle of the device listing.
Once the Medical Device Division completes its review and is satisfied with the technical evidence, the device is assigned a Hong Kong Medical Device (HKMD) number and included in the official registry.
The review process for a complete application typically follows a standardized administrative window. Once the listing is granted, the certificate remains valid for five years. Manufacturers and their LRPs must be mindful of the expiration date and should initiate the renewal process well in advance to ensure continuous market access.
Throughout the five-year validity period, any significant changes to the device, such as modifications to its design, intended use, or manufacturing site, must be reported. The LRP must submit a change notification to the MDD to ensure that the registry remains up to date. This ongoing management is essential for maintaining the integrity of the MDACS and ensuring that the devices on the market continue to meet the required safety standards.
Our standardized service process facilitates the efficient navigation of the Hong Kong administrative landscape to ensure your products meet all requirements of the MDD.
If you are interested in our Hong Kong MDACS registration services and wish to secure your market position, please feel free to contact us.
We're open for any suggestion or just have a chat with us.
Tel: Email: WhatsAPP